Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 13/20 | 0.61 |
| ▸ | MTNR1B | P49286 | 13/20 | 0.61 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.61 |
| ▸ | NQO2 | P16083 | 4/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.56 |
| ▸ | BLM | P54132 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 1/20 | 0.55 |
| ▸ | SPR | P35270 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31543627 | 0.88 | MTNR1A (0.60) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL31543656 | 0.88 | MTNR1A (0.60) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL25382276 | 0.88 | MTNR1A (0.60) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL26202196 | 0.84 | MTNR1A (0.69) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL29799281 | 0.84 | MTNR1A (0.55) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL25380213 | 0.84 | MTNR1A (0.55) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL26202894 | 0.82 | MTNR1A (0.53) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL13644764 | 0.80 | CYP1A2 (0.60) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL25295069 | 0.78 | MTNR1A (0.61) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 | |
| SCHEMBL29437233 | 0.78 | MTNR1A (0.61) | MTNR1AMTNR1BNOTUMNQO2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250057861-A1 | HALOGENATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2025-02-20 | — | — | US | disclosed |
| US-11998557-B2 | Halogenated psilocybin derivatives and methods of using | Enveric Biosciences Canada Inc. (CA) | 2024-06-04 | — | — | US | disclosed |
| US-20230293558-A1 | HALOGENATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | MAGICMED INDUSTRIES INC. (CA) | 2023-09-21 | — | — | US | disclosed |
| US-20230293558-A1 | HALOGENATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | MAGICMED INDUSTRIES INC. (CA) | 2023-09-21 | — | — | US | disclosed |
| EP-4208445-A1 | HALOGENATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-07-12 | — | — | EP | disclosed |
| CN-116348106-A | Halogenated nupharicin derivatives and methods of use | 恩维瑞克生物科学加拿大公司 | 2023-06-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293558-A1 | HALOGENATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | CES2, MAOB, CNR1 | MTNR1A 2036/4885MTNR1B 498/4885NOTUM 236/4885 |
| US-11998557-B2 | Halogenated psilocybin derivatives and methods of using | CES2, MAOB, CNR1 | MTNR1A 2036/4885MTNR1B 498/4885NOTUM 236/4885 |
| US-20250057861-A1 | HALOGENATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | CES2, MAOB, CNR1 | MTNR1A 2036/4885MTNR1B 498/4885NOTUM 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.